Studies on the effect of heat on the virus of serum hepatitis have shown that a mixture of normal serum albumin and proved icterogenic plasma failed to produce serum hepatitis when inoculated into volunteers after it had been heated at 600C. for 10 hours (1). Studies by Murray and Diefenbach (2) on the effect of heating infected plasma pools showed that after four hours heating at 600C. the infected plasma pools retained their ability to produce hepatitis. A statement was made in their paper that heating for four hours or more at 60°C. led to an increase in turbidity and formation of a precipitate (2). With these two facts in mind plus the fact that a plasma protein solution heated for 10 hours at 600C. might be clinically useful, we decided to investigate the possibility of preparing a plasma protein solution that could stand heating for 10 hours at 60°C. with little or no change in the proteins.
Studies on the effect of heat on the virus of serum hepatitis have shown that a mixture of normal serum albumin and proved icterogenic plasma failed to produce serum hepatitis when inoculated into volunteers after it had been heated at 600C. for 10 hours (1) . Studies by Murray and Diefenbach (2) on the effect of heating infected plasma pools showed that after four hours heating at 600C. the infected plasma pools retained their ability to produce hepatitis. A statement was made in their paper that heating for four hours or more at 60°C. led to an increase in turbidity and formation of a precipitate (2) . With these two facts in mind plus the fact that a plasma protein solution heated for 10 hours at 600C. might be clinically useful, we decided to investigate the possibility of preparing a plasma protein solution that could stand heating for 10 hours at 60°C. with little or no change in the proteins.
The present communication concerns the heat stability of the human plasma protein solution remaining after the crude fibrinogen and gamma globulin fractions have been separated from human plasma by ethanol-water mixtures at low temperatures.
METHODS AND RESULTS
The procedure for the separation of the crude fibrinogen fraction, Fraction I and the crude gamma globulin fraction, Fraction II + III was in part similar to that using ethanol at low temperatures (3) . Fractions I and II + III were removed from the starting plasma for three primary reasons. First, the proteins contained in these two fractions have only a minor role in the colloid osmotic pressure of plasma. Second, the proteins fibrinogen and gamma globulin, contained in Fractions I and II + III, respectively, could be salvaged for their specific clinical uses; i.e., afibrinogenemia, hemophilia and other coagulation component defects, agammaglobulinemia and specific infections requiring prophylaxis with antibodies. Third, Fractions I and II + III contain most of the more heat labile components of human plasma. The supernatant fluid following the removal of Fractions I and II + III was dried from the frozen state. The powder obtained was the material used in this investigation.
Plasma used in the preparation of this material was supplied by the American Red Cross through its Regional Blood Centers at Omaha, Nebraska, and Springfield, Missouri. The plasma was pooled at the Blood Center into two-liter bottles and ten liters were shipped to us each week. (4) .
The reconstituted material was sterilized by filtration through Hormann D-3, D-8 and D-10 filter pads, placed into sterile Coleman, Jr. Spectrophotometer tubes, and capped with sterile rubber stoppers. Some of the tubes were heated for 10 hours at 600C., while others not heated were used as control tubes. Optical density readings of both the heated and control tubes were made at 550 m,u in the Coleman Jr. Spectrophotometer. Figure 1A ). Very little of this component was seen in the unheated sample (lower diagram, Figure 1A ). Five minutes later this component was hardly discernible (arrow, upper diagram, Figure 1B ). Throughout the remainder of the run no components other than the main component in both the unheated and heated samples were seen in the ultracentrifuge pattern.
To ascertain to what extent the main component was decreased due to heating for 10 hours at 600C., the area of the main peak of each of the heated and unheated samples was determined from the picture taken 100 minutes after full speed had been attained ( Figure 1C The electrophoretic results obtained on the heated solution of Preparations 1, 2, and 3 showed the protein distribution to be very nearly the same as that in the starting material (Table I) . Al- bumin was approximately 80 per cent, alpha globulin 16 per cent, and beta globulin 4 per cent.
DISCUSSION
By the use of the cold ethanol method (3, 5 ), Pennell (6) has fractionated plasma to which either T6 phage virus or mouse SK polio virus had been added. He showed that for the most part both viruses were removed in Fractions I and II + III. The supernatant fluid following removal of Fraction II + III contained only a small percentage of the starting concentration of either virus. Murray (7) reported that albumin prepared by the cold ethanol method from a human plasma pool infected with homologous serum hepatitis was not infective in 10 volunteers when it had been heated for 10 hours at 60°C. When 100 ml. of 25 per cent albumin not heated for 10 hours at 60°C. were given to each of five volunteers, one case of hepatitis developed. Murray and Ratner (8) have demonstrated further that gamma globulin prepared by the cold ethanol method from human plasma infected with homologous serum hepatitis does not produce hepatitis in humans.
The work of Pennell and Murray suggests that both the cold ethanol fractionation process and the heating for 10 hours at 60°C. are responsible for the albumin solution being free of virus. The The upper diagrams represent the heated solution, the lower the unheated solution. Picture A was taken 5 minutes after reaching full speed (59,700 RPM); B, 10 minutes after full speed; and C, 100 minutes after full speed.
I l ] I i l method described in this communication makes use of the cold ethanol process to remove the more unstable proteins thus permitting heating for 10 hours at 60°C. A study of this process on plasma infected with homologous serum hepatitis is indicated. If proven successful in human volunteers, the plasma protein solution resulting could be prepared on a large scale more economically than can albumin with equipment that already exists in the industrial laboratories.
Preliminary studies suggest that acetyl-dl-tryptophanate is a stabilizing agent for the plasma protein solution. The present method is being studied on a pilot plant scale by the Biologic Laboratories, Massachusetts Department of Public Health, Boston. Large volumes of the solution containing acetyl-dl-tryptophanate are being heated for 10 hours at 600C. SUMMARY 1. A method for the preparation of a stable human plasma protein solution involving the removal of the more heat labile components from plasma with ethanol-water mixtures has been described.
2. The solution contains nearly all the albumin and some of the small molecular weight globulins that are normally contained in plasma.
3. Very little, if any change is observed in the optical density and electrophoretic distribution of the solution following heating for 10 hours at 600C. 4 . Ultracentrifugal analyses show the formation of a fast moving component in the solution due to the 10 hours' heating at 600C.
